Ralph. Obelix . Hope you okay guys. The bb is very interesting now. I am so happy now with these events happening but I personally think the main priority for the bod to present the best way to attract big client at the moment after Page meeting will see few big contract will be signing and that is changing the company to go towards transformation stage. Gla
Many of us here believe that VAL201 will push PYC to higher level Mate. If you have some spare cash Buy into. However, if nothing happens from VAL they have more projects in the pipeline with others Bio Pharma Also, read some post from Ralph, Draey and Honda they always provide good information about PYC. Good luck to you whatever your decision Mate, but don't forget to DYOR before. Obelix
Thanks Mate, I didn't know till I post here for us. Guys, I'm really sorry for my mistake (previous post at 11.34am) Shares Magazine article, but I ask on VAL - BB for the new link. Soon I get I'll post here. Apologies, for my mistake. Hope tomorrow We can see a blue day again Thanks to all Obelix
Just been reading posts on Val thread, looks to be promising for Val 201 with results they have been researching with on Brest Cancer in Finland, exciting reading on there at the moment, and as mentioned Val 201 had promising results on the Prostrate Cancer research. Good day for Val tomorrow, should bold well for your investment there, good luck to you mate.
The attached is a old version. Today's publication provided good info on VAL 201 and confirmed the human trials will go ahead very soon, also provided updates on 201 and 401, plus details of the obtained patents and Eurostar grants.
All very good and real momentum now. Anticipating the RNS anyday soon which will be game changing for Valirx.
The SP needs ammunition, and this is not forthcoming from the company yet. Next we have the Workshop on Virtual Tumour Clinical within Translational Science â€“ June 10, 2014, Alicante (Spain) Physiomics will present a half-day workshop on â€œApplications of Physiomicsâ€™ Virtual Tumour Clinical within Translational Scienceâ€, on the June 10, 1:30 pm â€“ 4:30 pm ahead of the 2014 PAGE meeting that will take place in Alicante (Spain).
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.